BioSpace News Archive

Clarius Mobile Health, a pioneer and innovator in high definition medical imaging devices, today announced increased adoption of its Clarius L7 HD handheld ultrasound scanner by interventional pain management specialists for needle-guided injections.

United Spinal Association has announced the launch of a comprehensive disaster preparedness initiative for individuals with spinal cord injuries and disorders designed to lessen the effects and risks associated with natural or human-caused disasters.

Todos Medical (TOMDF) an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimers disease, along with Adial Pharmaceuticals, Inc.

Strataca Systems, Ltd., a clinical stage company developing medical devices designed to improve kidney function in patients with congestion and fluid overload, today announces new animal data presented during Kidney Week which has been posted on the conference website. The study features the company’s JuxtaFlow® renal negative pressure treatment (rNPT) device demonstrating improved kidney function, including increased urine output, sodium excr

Cleveland Clinic Rehabilitation Hospitals, a joint venture partnership between Select Medical and Cleveland Clinic, have been recognized as the “Best Physical Rehabilitation Centers in Ohio” by Newsweek Magazine, which partnered with global market research firm, Statista Inc., in its first ranking of the country’s top facilities for rehabilitation care.

RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, today announced that seven clinical abstracts evaluating the use of its novel technology were accepted for presentation during the virtual American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, Oct. 24-28.

WellSky, a global health and community care technology company, today announced that it will deliver the American Red Cross a range of new technology solutions to support the development by the Red Cross of specialty blood products and complex testing.

bioAffinity Technologies, a privately held biotech company, announced its poster “Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity” has been accepted for presentation at the International Association for the Study of Lung Cancer (IASLC) 2020 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer

– Lumasiran Demonstrated a 72 Percent Mean Reduction in Urinary Oxalate and Improvements in Nephrocalcinosis in ILLUMINATE-B Phase 3 Study in Children Under the Age of Six and as Young as Three Months – – Alnylam Also Presents New Results from the 12-Month Extension Period of the ILLUMINATE-A Pivotal Study,

The Notes will be secured obligations of Imagin; will accrue 10% interest annually, payable semi-annually in arrears; and will mature 18 months following the date of issue, unless earlier repurchased, redeemed or converted.